Project Grant R01NS135616
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $816,063 to The Trustees of Columbia University in the City of New York to conduct research on the neural mechanisms underlying how social stimuli elicit motivated behavior. The key focus of the research is to understand how neural representations of social rank information, such as dominant and submissive social cues, converge onto brain...
- This $180,497 federal Project Grant awarded by the National Institute of Neurological Disorders and Stroke (NINDS) on August 15, 2023 will support research at Oregon Health & Science University (OHSU) to investigate the circuit architecture and dynamics of the insular cortex and its role in motivational behaviors. The key objectives of the project are to: 1) use machine learning-based algorithms to comprehensively identify functional subdivisions, neuronal types, and cell-specific...
- This Project Grant award of $711,897.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants (CFDA 93.242) program supports research to explore the role of serotonin in modulating aggressive and prosocial behaviors. The key research objectives are to: Characterize the temporal dynamics of serotonin's effects on aggression and prosocial behavior using optogenetic manipulations and serotonin sensor recordings. Identify the specific subpopulations of neurons...
- This federal Project Grant award of $606,029.00 from the National Institute of Mental Health (NIMH) under the Mental Health Research Grants program (CFDA 93.242) will support research at the University of Massachusetts Medical School (UMass Medical) to investigate the neurocircuitry underlying motivated reward-seeking behavior in response to stress. The key goals of the research are to: 1) Determine if a subpopulation of GABAergic neurons in the medial habenulo-interpeduncular (MHB-IPN) axis...
- This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, is supporting a collaborative research initiative to elucidate how human microglia-like cells leverage mRNA translational control mechanisms to respond to environmental cues. The $489,500 award, with a period of performance from July 1, 2025 to June 30, 2027, will enable researchers at...
- This federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the 21st Century Cures Act - Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative (CFDA 93.372), provides $828,335 to the University of Chicago to investigate the roles of inhibitory and disinhibitory neural circuits in the formation, stabilization, and competition of neural assemblies in the cortex. The project aims to experimentally test theoretical...
- This Project Grant award from the National Institute of Mental Health (NIMH), under the Mental Health Research Grants program (CFDA 93.242), provides $549,140 to the University of Miami to investigate the role of the bacterial signaling molecule autoinducer-2 (AI-2) in mediating the mammalian stress response and its impact on stress-related behaviors and neurobiological factors. The 5-year project aims to: 1) determine if stress regulates gut bacterial production of AI-2, 2) assess how bacterial...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a Project Grant of $246,623 to New York University School of Medicine under the Allergy and Infectious Diseases Research (CFDA 93.855) federal grant program. The goal of this 2-year project is to investigate the molecular mechanisms that control the tolerogenic function of dendritic cells (DCs), which play a critical role in regulating immune homeostasis and promoting tolerance. The proposed research aims to: 1) identify...
- This Project Grant award of $554,874 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research program) supports research at Northern Illinois University to investigate the role of the gut-brain-microbiota axis in the development of inflammatory bowel disease (IBD) induced by long-term stress. The key objectives are to determine how prolonged social isolation and IBD induction affect the gut microbiome of...
- This federal Project Grant award from the National Institute of Mental Health (CFDA 93.242 Mental Health Research Grants) provides $460,855 to New York University School of Medicine to investigate the cellular and circuit mechanisms by which acetylcholine (ACh) promotes associative learning in the primary somatosensory cortex. The key objectives are to: 1) use fluorescent ACh sensors and chemogenetic techniques to study the magnitude and time course of ACh release during different phases of an...
ELUCIDATING NEURAL MECHANISMS UNDERLYING SICKNESS BEHAVIORS - ABSTRACT SICKNESS BEHAVIORS REPRESENT A RANGE OF BEHAVIORAL CHANGES THAT MANIFEST IN RESPONSE TO INFECTION OR INFLAMMATION. THESE CHANGES INCLUDE REDUCED PHYSICAL ACTIVITY, DIMINISHED SOCIAL INTERACTION, AND ALTERED FEEDING BEHAVIOR. IT IS SUGGESTED THAT THESE BEHAVIORAL SHIFTS ARE INTEGRAL TO THE BODY'S IMMUNE RESPONSE AGAINST PATHOGENS, SERVING TO CONSERVE ENERGY, DEPRIVE PATHOGENS OF NUTRIENTS, AND CONTAIN THE INFECTION WITHIN THE HOST'S COMMUNITY. NEVERTHELESS, THE MECHANISMS BEHIND THE INITIATION OF SICKNESS BEHAVIORS AT THE LEVEL OF NEURONS AND NEURAL CIRCUITS REMAIN LARGELY UNEXPLORED. THIS RESEARCH ENDEAVORS TO FILL THIS KNOWLEDGE GAP BY IDENTIFYING A NEURAL SUBSTRATE THAT ACTS AS A POINT OF INTERACTION BETWEEN THE IMMUNE AND NERVOUS SYSTEMS. CYTOKINES, SIGNALING MOLECULES PRODUCED BY VARIOUS IMMUNE CELLS, PLAY A PIVOTAL ROLE IN MOUNTING THE BODY'S IMMUNE RESPONSE AGAINST PATHOGENIC THREATS. A GROWING BODY OF EVIDENCE SUGGESTS THAT CYTOKINES CAN ALSO FUNCTION AS NEUROMODULATORS BY ACTING ON RECEPTORS EXPRESSED ON NEURONS WITHIN THE CENTRAL NERVOUS SYSTEM. IL-1B IS ONE SUCH CYTOKINE THAT HAS BEEN STRONGLY ASSOCIATED WITH THE GENERATION OF SICKNESS BEHAVIORS. IN SUPPORT OF THIS IDEA, OUR DATA HAS REVEALED ENRICHMENT OF ITS RECEPTOR, IL-1R1, WITHIN THE DORSAL RAPHE NUCLEUS (DRN), A BRAIN REGION WELL-KNOWN FOR ITS INVOLVEMENT IN REGULATING BEHAVIORS ALTERED DURING SICKNESS. THESE OBSERVATIONS SUGGEST THAT IL-1B MIGHT ACT DIRECTLY ON IL-1R1-EXPRESSING NEURONS OF THE DRN (IL-1R1DRN) TO PROMOTE THE EXPRESSION OF SICKNESS BEHAVIORS. IN THIS APPLICATION, WE WILL TEST THIS HYPOTHESIS USING A RANGE OF MOLECULAR, GENETIC, AND SYSTEMS NEUROSCIENCE METHODS. SPECIFICALLY, IN AIM 1, WE WILL COMPREHENSIVELY EXAMINE IL-1R1 EXPRESSION IN THE DRN AND MONITOR THE ACTIVITY OF DRN NEURONS IN RESPONSE TO IL-1B AND INFLAMMATION. IN AIM 2, WE WILL MANIPULATE THE ACTIVITY OF IL-1R1DRN NEURONS TO INVESTIGATE THEIR ROLE IN MODULATING SICKNESS BEHAVIORS. WE WILL ALSO EXPLORE WHETHER IL-1 RECEPTOR EXPRESSION ITSELF IN THE DRN IS ESSENTIAL FOR GENERATING SICKNESS BEHAVIORS. FINALLY, IN AIM 3, WE WILL IDENTIFY DOWNSTREAM TARGETS OF IL-1R1DRN NEURONS THAT MEDIATE SICKNESS BEHAVIORS WHILE SIMULTANEOUSLY ASKING WHETHER IL-1R1DRN RELIES ON A SINGLE TARGET TO INDUCE ALL SICKNESS BEHAVIORS OR IF IT UTILIZES DIFFERENT TARGETS FOR GENERATING DISTINCT TYPES OF SICKNESS BEHAVIORS. IN SUMMARY, OUR STUDY WILL IDENTIFY IL-1R1DRN AND ITS ASSOCIATED TARGETS AS THE PRIMARY NEURAL CIRCUITS INFLUENCED BY THE PRO-INFLAMMATORY CYTOKINE IL-1B IN DRIVING BEHAVIORAL CHANGES DURING SICKNESS. SUCCESSFUL COMPLETION OF THIS RESEARCH WILL OFFER NEURAL CIRCUIT-FOCUSED INSIGHTS INTO HOW CHANGES IN THE IMMUNE SYSTEM UNDER INFLAMMATORY CONDITIONS CAN LEAD TO CORRESPONDING ALTERATIONS IN BEHAVIOR.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $474.3k | 6/9/25 | ||
| Not listed | $473.8k | 7/1/24 | ||
| Not listed | $473.8k | 7/1/24 |